Award
Delivery Order #SPE2DR26F69C1
Delivery Order for NovoLog Insulin by AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$1,199.97
Ceiling
$1,199.97
Awarded
February 24, 2026
Period of Performance
Feb 24, 2026 – Feb 25, 2026
Identifier
SPE2DR26F69C1
NAICS
424210
This award represents a definitive delivery order under the indefinite delivery vehicle (IDV) previously awarded to AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor. The contract procures NovoLog insulin FlexPen, a critical medication for diabetes management, ensuring the agency's healthcare operations have timely access to essential pharmaceutical products. The work scope includes the delivery of the specified insulin product in precise quantities to a designated location, reflecting the contract's role in supporting public health missions. As a follow-on order under a competitive IDV, the delivery order maintains continuity in pharmaceutical supply services. The order is scheduled for a short-term fulfillment within a defined two-day performance period. This procurement upholds the agency's commitment to reliable medication availability for patient care.
Description
4570941118!NOVOLOG 100 UNIT/ML FLEXPEN 3ML